Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective β-isoform-selective inhibitor
- Author
- AIELLO, L. P1 2 3 ; BURSELL, S.-E1 2 3 ; SMITH, L. E. H3 6 ; KING, G. L1 3 7 ; CLERMONT, A1 2 3 ; DUH, E1 ; ISHII, H1 ; TAKAGI, C1 ; MORI, F1 ; CIULLA, T. A4 ; WAYS, K5 ; JIROUSEK, M5
[1] Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, United States
[2] Beetham Eye Institute, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts, United States
[3] Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
[4] Department of Ophthalmology, Indiana University, Indianapolis, Indiana, United States
[5] Lilly Research Laboratories, Indianapolis, Indiana, United States
[6] Department of Ophthalmology, Children's Hopsital, Boston, Massachusetts, United States
[7] Department of Medicine, Brigham & Women's Hospital, Boston, Massachusetts, United States - Source
Diabetes (New York, NY). 1997, Vol 46, Num 9, pp 1473-1480 ; ref : 40 ref
- CODEN
- DIAEAZ
- ISSN
- 0012-1797
- Scientific domain
- Endocrinology; Nutrition, obesity, metabolic disorders
- Publisher
- American Diabetes Association, Alexandria, VA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Animal Cellule endothéliale Complication Diabète Facteur croissance endothélium vasculaire Forme moléculaire In vitro Perméabilité Protein kinase C Rat Rétine Rétinopathie Traitement Voie intravitréenne Voie orale Appareil visuel Endocrinopathie Enzyme In vivo Mammalia Oeil pathologie Oeil Rodentia Transferases Vaisseau sanguin Vertebrata
- Keyword (en)
- Animal Endothelial cell Complication Diabetes mellitus Vascular endothelium growth factor Molecular form In vitro Permeability Protein kinase C Rat Retina Retinopathy Treatment Intravitreous administration Oral administration Visual system Endocrinopathy Enzyme In vivo Mammalia Eye disease Eye Rodentia Transferases Blood vessel Vertebrata
- Keyword (es)
- Animal Célula endotelial Complicación Diabetes Factor crecimiento endotelio vascular Forma molecular In vitro Permeabilidad Protein kinase C Rata Retina Retinopatía Tratamiento Vía intravítrea Vía oral Aparato visual Endocrinopatía Enzima In vivo Mammalia Ojo patología Ojo Rodentia Transferases Vaso sanguíneo Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02M Eye
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2792069
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.2337/diab.46.9.1473 
https://dx.doi.org/10.2337/diab.46.9.1473
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.2337\/diab.46.9.1473\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1480\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"AIELLO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"BURSELL, S.-E\";i:1;s:14:\"SMITH, L. E. H\";i:2;s:10:\"KING, G. L\";i:3;s:11:\"CLERMONT, A\";i:4;s:6:\"DUH, E\";i:5;s:8:\"ISHII, H\";i:6;s:9:\"TAKAGI, C\";i:7;s:7:\"MORI, F\";i:8;s:12:\"CIULLA, T. A\";i:9;s:7:\"WAYS, K\";i:10;s:11:\"JIROUSEK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.2337\/diab.46.9.1473\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1480\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"AIELLO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"BURSELL, S.-E\";i:1;s:14:\"SMITH, L. E. H\";i:2;s:10:\"KING, G. L\";i:3;s:11:\"CLERMONT, A\";i:4;s:6:\"DUH, E\";i:5;s:8:\"ISHII, H\";i:6;s:9:\"TAKAGI, C\";i:7;s:7:\"MORI, F\";i:8;s:12:\"CIULLA, T. A\";i:9;s:7:\"WAYS, K\";i:10;s:11:\"JIROUSEK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.2337\/diab.46.9.1473\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.2337\/diab.46.9.1473\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1480\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"AIELLO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"BURSELL, S.-E\";i:1;s:14:\"SMITH, L. E. H\";i:2;s:10:\"KING, G. L\";i:3;s:11:\"CLERMONT, A\";i:4;s:6:\"DUH, E\";i:5;s:8:\"ISHII, H\";i:6;s:9:\"TAKAGI, C\";i:7;s:7:\"MORI, F\";i:8;s:12:\"CIULLA, T. A\";i:9;s:7:\"WAYS, K\";i:10;s:11:\"JIROUSEK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.2337\/diab.46.9.1473\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1480\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"AIELLO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"BURSELL, S.-E\";i:1;s:14:\"SMITH, L. E. H\";i:2;s:10:\"KING, G. L\";i:3;s:11:\"CLERMONT, A\";i:4;s:6:\"DUH, E\";i:5;s:8:\"ISHII, H\";i:6;s:9:\"TAKAGI, C\";i:7;s:7:\"MORI, F\";i:8;s:12:\"CIULLA, T. A\";i:9;s:7:\"WAYS, K\";i:10;s:11:\"JIROUSEK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.2337\/diab.46.9.1473\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:9:\"\u0000*\u0000jtitle\";s:23:\"Diabetes (New York, NY)\";s:9:\"\u0000*\u0000stitle\";s:18:\"Diabetes (N.Y. NY)\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"46\";s:8:\"\u0000*\u0000issue\";s:1:\"9\";s:8:\"\u0000*\u0000spage\";s:4:\"1473\";s:8:\"\u0000*\u0000epage\";s:4:\"1480\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0012-1797\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"AIELLO\";s:10:\"\u0000*\u0000aufirst\";s:4:\"L. P\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:13:\"BURSELL, S.-E\";i:1;s:14:\"SMITH, L. E. H\";i:2;s:10:\"KING, G. L\";i:3;s:11:\"CLERMONT, A\";i:4;s:6:\"DUH, E\";i:5;s:8:\"ISHII, H\";i:6;s:9:\"TAKAGI, C\";i:7;s:7:\"MORI, F\";i:8;s:12:\"CIULLA, T. A\";i:9;s:7:\"WAYS, K\";i:10;s:11:\"JIROUSEK, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"DIAEAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:172:\"Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective \u03b2-isoform-selective inhibitor\";s:8:\"\u0000*\u0000place\";s:14:\"Alexandria, VA\";s:6:\"\u0000*\u0000pub\";s:29:\"American Diabetes Association\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
